Laurence A Fissette

机构：GlaxoSmithKline (Belgium) · ORCID：0000-0002-6483-6558

发表论文 36 篇 · 总被引 1867 次 · h-index 14

代表论文

Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults (2023 · New England Journal of Medicine · 被引 794)
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons (2024 · Clinical Infectious Diseases · 被引 176)
Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans (2017 · Frontiers in Immunology · 被引 155)
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial (2022 · The Journal of Infectious Diseases · 被引 124)
Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial (2016 · Clinical Immunology · 被引 116)
Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans (2019 · Vaccine · 被引 80)